Cardiex

SphygmoCor® Technology: This is Cardiex's groundbreaking technology, which has set the benchmark for noninvasive measurement of central aortic pressures and related arterial health characteristics, collectively known as vascular biomarkers. This technology has been extensively researched and detailed in numerous peer-reviewed journals, and it is used to assess cardiovascular risk, predict organ damage, and guide disease management.

The SphygmoCor XCEL is a non-invasive device used for measuring central blood pressure and arterial stiffness.

The SphygmoCor XCEL is a non-invasive device used for measuring central blood pressure and arterial stiffness.

Comprehensive Insights Into Cardiovascular Health

The SphygmoCor XCEL is a cutting-edge vascular biometric monitor designed to provide comprehensive central hemodynamics and arterial stiffness insights, enabling full visibility into cardiovascular health. By measuring both central and brachial blood pressures, it offers critical insights into cardiovascular function.

Cardiex Features

Key Features

  • Noninvasive Measurement: The SphygmoCor XCEL enables the noninvasive assessment of central aortic pressure waveforms and vascular biomarkers that are crucial for understanding cardiovascular health.
  • Advanced Physiological Measurements: It assesses vascular biomarkers for a thorough understanding of arterial stiffness and overall arterial health. This allows for early detection of potential cardiovascular issues, guiding targeted interventions for improving cardiovascular health.

Importance of Arterial Health

The need for new methods to assess arterial pressure and flow dynamics is highlighted by the Lancet Commission on Hypertension. Traditional methods often focus solely on upper-arm blood pressure, overlooking vital insights offered by advanced measurements.

Pulse Wave Analysis (PWA)

  • What It Does: PWA analyzes the characteristics of the arterial pulse wave, providing valuable insights into the elasticity and compliance of arterial walls.
  • Benefits: This analysis goes beyond conventional blood pressure measurements, offering a comprehensive understanding of vascular health and aiding in early detection of cardiovascular risk.

Pulse Wave Velocity (PWV)

  • Definition: PWV measures the speed at which the arterial pulse travels through the circulatory system. Elevated PWV is a key indicator of arterial stiffness.
  • Significance: Monitoring PWV is crucial for assessing vascular aging and guiding interventions to maintain or enhance cardiovascular health.

Comprehensive Parameter Overview

The SphygmoCor XCEL provides a wide range of measurements that are essential for evaluating cardiovascular health:

ParameterDescription
Heart Rate (HR)Beat-to-beat measurement aligned with standard ECG methods.
Brachial Blood PressurePressure at the brachial artery; high levels are a major risk factor for heart disease.
Central Blood PressureMore accurate predictor of subclinical cardiovascular disease than traditional brachial blood pressure.
Central Pulse PressureIndicates the pressure experienced by major organs, essential for assessing end organ damage risk.
Augmentation Pressure (AP)Marker indicating arterial stiffness; elevated levels reflect increased cardiovascular risk.
Augmentation Index (AIx)Another indicator of arterial stiffness, reflecting the burden on the heart.
Subendocardial Viability Ratio (SEVR)Insight into how well the heart copes with exercise stress.
Pulse Pressure Amplification (PPA)Provides insights into arterial stiffness and efficiency of blood flow distribution.
Pulse Wave Velocity (PWV)Key indicator of arterial stiffness and cardiovascular risk.
SphygmoCor Reference AgeEstimated arterial age based on central pressure and stiffness parameters.

Trusted Technology

Founded on over 40 years of hemodynamic studies and validated by more than 20 years of research, SphygmoCor technology is trusted by researchers worldwide. It has supported clinical trials across various therapeutic areas, including hypertension, heart failure, chronic kidney disease, COPD, and diabetes.

For clinical research or practice, the SphygmoCor XCEL stands as a pivotal tool for understanding cardiovascular health and guiding patient management strategies effectively.

For more information on the SphygmoCor XCEL and its applications, please contact us.